Azitra, Inc. (AZTR)
NYSEAMERICAN: AZTR · Real-Time Price · USD
0.1795
-0.0005 (-0.28%)
At close: Sep 4, 2026, 4:00 PM EDT
0.1794
-0.0001 (-0.06%)
After-hours: Sep 4, 2026, 8:00 PM EDT
Azitra Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
13
Market Cap
10.88M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 7.50K | -678.50K | -98.91% |
| Dec 31, 2023 | 686.00K | 402.00K | 141.55% |
| Dec 31, 2022 | 284.00K | 174.00K | 158.18% |
| Dec 31, 2021 | 110.00K | -315.00K | -74.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Xenetic Biosciences | 3.26M |
| Vistagen Therapeutics | 2.50M |
| Daré Bioscience | 1.37M |
| CytoMed Therapeutics | 669.28K |
| Senti Biosciences Holdings | 55.00K |
| Kiora Pharmaceuticals | 20.00K |
AZTR News
- 17 days ago - Azitra regains NYSE American compliance - TheFly
- 17 days ago - Azitra, Inc. Regains Compliance with NYSE American Continued Listing Standards - PRNewsWire
- 21 days ago - Azitra reports Q2 EPS (17c) vs. ($1.18) last year - TheFly
- 25 days ago - Azitra, Inc. Announces Q2 2026 Results and Provides Business Updates - PRNewsWire
- 26 days ago - Azitra Quarterly report: Q2 2026 - Filings
- 26 days ago - Azitra Earnings release: Q2 2026 - Filings
- 5 weeks ago - Meet Azitra: Fly Exclusive with CEO Francisco Salva - TheFly
- 5 weeks ago - Azitra building multi market microbial engineering platform, CEO says - TheFly